- Home >
- Clinicals Trials >
- CA073-1020
Lymphoma
CA073-1020
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants with Previously Untreated High-risk Large B-cell Lymphoma (GOLSEEK-1)
- Open at Saint-Cloud since : 27/11/2024
- Target : Adult
- Phase : Phase III
Trial description
To evaluate the efficacy of;golcadomide plus R-CHOP vs;placebo-R-CHOP in participants with;untreated high-risk large B-cell;lymphoma with respect to PFS as;assessed by the investigator.;To evaluate the efficacy of;Golcadomide plus R-CHOP vs;placebo-R-CHOP in participants with;untreated high-risk large B-cell lymphoma with respect to CMR as assessed by the IRAC.;À To evaluate the efficacy of;Golcadomide plus R-CHOP vs;placebo-R-CHOP in participants with;untreated high-risk large B-cell;lymphoma with respect to MRD;negativity at EOT.;To evaluate the efficacy of;golcadomide plus R-CHOP vs;placebo-R-CHOP in participants with;untreated high-risk large B-cell;lymphoma with respect to OS.;À To evaluate the efficacy of;golcadomide plus R-CHOP vs;placebo-R-CHOP in participants with;untreated high-risk LBCL with respect;to EFS as assessed by the investigator.
Url of the trialMain investigator
